Jan Malcolm
Director at UNITED THERAPEUTICS Corp (UTHR) since June 2024
Jan Malcolm has filed 13 insider reports with the SEC since June 2024, as director at UNITED THERAPEUTICS Corp (UTHR). In the last 12 months Jan Malcolm sold $348K of stock on the open market. The latest filing, on July 23, 2026, reports grant or award at UNITED THERAPEUTICS Corp (UTHR).
- Filings
- 13
- Companies
- 1
- Bought on market
- None
- Sold on market
- $628K
Companies where Jan Malcolm is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince June 2024 | 450 | $628K | $577.34 | Jul 23, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 22, 2026UTHRSEC Form 4 filed by Director Malcolm JanForm 4Grant or award
- Jul 10, 2026-$179KUTHRDirector Malcolm Jan converted options into 650 shares and sold $178,942 worth of shares (325 units at $550.59) as part of a pre-agreed trading plan, increasing direct ownership by 260% to 450 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 17, 2026-$24KUTHRDirector Malcolm Jan sold $24,008 worth of shares (45 units at $533.51), decreasing direct ownership by 26% to 125 unitsForm 4Open-market sale10b5-1 plan
- Feb 17, 2026-$23.7KUTHRDirector Malcolm Jan sold $23,734 worth of shares (50 units at $474.68), decreasing direct ownership by 19% to 220 unitsForm 4Open-market sale10b5-1 plan
- Feb 3, 2026-$23.7KUTHRDirector Malcolm Jan sold $23,712 worth of shares (50 units at $474.23), decreasing direct ownership by 16% to 270 unitsForm 4Open-market sale10b5-1 plan
- Jan 16, 2026-$23KUTHRDirector Malcolm Jan sold $23,049 worth of shares (50 units at $460.98), decreasing direct ownership by 14% to 320 unitsForm 4Open-market sale10b5-1 plan
- Jan 5, 2026-$24.8KUTHRDirector Malcolm Jan sold $24,750 worth of shares (50 units at $495.01), decreasing direct ownership by 12% to 370 unitsForm 4Open-market sale10b5-1 plan
- Dec 23, 2025-$25.6KUTHRDirector Malcolm Jan sold $25,606 worth of shares (50 units at $512.12), decreasing direct ownership by 11% to 420 unitsForm 4Open-market sale10b5-1 plan
- Dec 11, 2025-$24.1KUTHRDirector Malcolm Jan sold $24,149 worth of shares (50 units at $482.98), decreasing direct ownership by 10% to 470 unitsForm 4Open-market sale10b5-1 plan
- Sep 9, 2025-$280KUTHRDirector Malcolm Jan sold $280,203 worth of shares (700 units at $400.29), decreasing direct ownership by 57% to 520 unitsForm 4Open-market sale
- Jul 25, 2024UTHRSEC Form 4 filed by Director Malcolm JanForm 4Grant or award
- Jun 26, 2024UTHRSEC Form 4 filed by Director Malcolm JanForm 4Grant or award
- Jun 26, 2024UTHRJan Malcolm became an insiderForm 3New insider
Compare Jan Malcolm with
- Jan Malcolm vs Martine A Rothblatt1 shared
- Jan Malcolm vs Christopher Patusky1 shared
- Jan Malcolm vs Paul A Mahon1 shared
- Jan Malcolm vs Nilda Mesa1 shared
- Jan Malcolm vs Victor J Dzau1 shared
- Jan Malcolm vs Linda Maxwell1 shared
Other insiders at the same companies
- Martine A RothblattUTHR
- Christopher PatuskyUTHR
- Paul A MahonUTHR
- Nilda MesaUTHR
- Victor J DzauUTHR
- Linda MaxwellUTHR
- Tommy G ThompsonUTHR
- Kevin TraceyUTHR
- Judy D. OlianUTHR
- Louis W SullivanUTHR
- Christopher CauseyUTHR
- Richard GiltnerUTHR
- Ray KurzweilUTHR
- James EdgemondUTHR
- Michael BenkowitzUTHR
- Raymond DwekUTHR
Questions about Jan Malcolm
- What is Jan Malcolm's role at UNITED THERAPEUTICS Corp?
- Jan Malcolm reports to the SEC as director at UNITED THERAPEUTICS Corp (UTHR), according to the latest filing on July 23, 2026.
- How many shares does Jan Malcolm own?
- After the latest filing that states it, Jan Malcolm directly owned 450 shares of UNITED THERAPEUTICS Corp (UTHR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jan Malcolm bought or sold stock recently?
- The most recent open-market sale was on July 10, 2026: sold 325 shares of UNITED THERAPEUTICS Corp (UTHR) for $179K at an average of $550.59.
- How do I get alerts when Jan Malcolm files?
- Follow Jan Malcolm on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Jan Malcolm (SEC CIK 0002028640). Totals count each trade once, skipping amendments whose original is on file, from Jun 28, 2024 on. View on SEC EDGAR